Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,065 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,373
Recruiting: 800
Ph III recruiting: 82
Growth YoY: +14.1%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (618)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07298577	Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer(STOPHCC-GAAD)	enrolling by invitation	N/A	2,100	Siriraj HospitalOTHER	1	Apr 24, 2026	clinicaltrials
NCT07533825	Laparoscopic Staging for Stage III Gastric Cancer(CGCA202501)	enrolling by invitation	N/A	968	Tianjin Medical University Cancer Institute and Hospital